Clinical trial
Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis
NCT00259558 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00259558 |
|---|---|
| Title | Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis |
| Official title | Prospektive, Randomisierte Doppelblinde Studie Zur Dosisfindung Von Intestinal Redardiert Freigesetztem Phosphatidylcholin Bei Chronisch Aktiver Pancolitis Ulcerosa |
| Lead sponsor | Heidelberg University, Other |
| Collaborators | Prof. Wolfgang Stremmel Dietmar Hopp Stiftung |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | retarded release phosphatidylcholine |
| Enrollment | 60 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Nov 29, 2005 |
| Last update posted | Feb 12, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: